Research & Development: Page 95
-
PharmaVoice Team/PharmaVoice
Depression: The Market for Lifting Moods
By Cynthia Borda The antidepressant market, while mature, is dynamic. Various market shapers — including increased regulatory oversight and safety-labeling changes; imminent loss of patent protection for some leading products; and the development of new drug formulations and classes — are influen...
By Cynthia Borda • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
E-Media
Skyscape Releases Mobile Drug Usage Reference Software Skyscape Inc. has released FamilyRx: AHFS Patient Drug Information, a mobile medical reference that places trusted, up-to-date information on proper medication usage into the hands of patients and their families. FamilyRx is available for use...
By PharmaVoice Team • Jan. 2, 2008 -
Explore the Trendline➔
Stock via Getty Images
TrendlineArtificial intelligence & machine learning
After years of excited buzz around the potential of artificial intelligence and machine learning, pharma has begun to realize the true implications and potential value of these technologies.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
PharmaTrax
Converting Service Channels Into Sales Channels Promises Profit Growth Faced with escalating market demands to produce greater returns from existing corporate assets, executives at leading Fortune 500 organizations are increasingly converting traditional service channels into high-performance sal...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
On the Calendar
Your Source for Life-Sciences Events and Conference Information Professional education is an ongoing endeavor for most executives. PharmaVOICE has partnerships with every major conference provider serving the life-sciences industry. PharmaVOICE is distributed at more than 150 industry events a ye...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
On the Calendar
Mach 2006 On the Calendar March 20-21 2nd Annual Pharmaceutical Accounting and Reporting Congress Crowne Plaza Hotel, Philadelphia For more information, contact Jon Stock, Center for Business Intelligence, at 800-817-8601, e-mail [email protected], or visit cbinet.com. March 20-21 10th Internati...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Sense and Sensibility -- Pamela Williamson Joyce
With a wide and deep understanding of the inner sanctum of numerous departments in the life sciences, Pamela Williamson Joyce has been able to bring both inventiveness and clear-headed thinking to Serono’s regulatory practice, helping the company to bring many new products to market. The path to ...
By Kim Ribbink • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Table of Contents
Table of Contents January 2006 On the Cover Competitive intelligence: The eyes and ears of the industry Shrinking pipelines, increased regulatory scrutiny, and the emergence of clinical-trial registries are just a few of the factors that are creating a tougher environment for industry players and...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
HBA Unleashes the Power of Being
Becoming an Agent of Change Was the Focus of the 2005 Leadership Conference by Marie Tartaglio, M.Ed., Director, Training & Learning Strategy, Scientific Advantage LLC, and Donna Ramer, President, StrategCations Inc., Member, HBA Board of Directors “Successful leaders are adept at mastering c...
By Marie Tartaglio • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
Ringing in a new year of change Taren Grom, Editor of PharmaVOICE, and Mary Alice Raudenbush, VP of Regulatory Affairs at Endo Pharmaceuticals, share a moment during the recent HBA Leadership Conference in Baltimore, the focus of which was becoming an agent of change. HBA Leadership Conference Ri...
By Taren Grom • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Alzheimer's Disease: Untangling the Brain's Mystery
By Cynthia Borda As the population ages, the prevalence of Alzheimer’s disease (AD) is expected to increase. But there is no real way to diagnose the disease and drugs currently on the market only treat the symptoms of Alzheimer’s. At the same time, analysts say there is tremendous opportunity fo...
By Cynthia Borda • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
PharmaVOICE is pleased to present our annual Year in Preview issue. Our thanks to the more than 135 thought leaders who generously took the time to take stock of what they believe are the most-pressing issues the industry will face in the coming year. These hot trends address issues that will imp...
By Taren Grom • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Year in Preview -- Featured Experts
Featured Experts Indexed by Section Introduction Introduction Murray Aitken. IMS Health Rudy Bakalov, CISSP. Ernst & Young LLP Daniel B. Carr, M.D. Javelin Pharmaceuticals Inc. Mark A. Goldberg, M.D. Perceptive Informatics, Parexel International Cort Grey. Dendrite Clinical Travis Hollingswor...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Cover
Year in Preview 2006 More than 135 experts talk about the industry’s future The Forum for the Industry Executive December 2005 Special Issue www.pharmavoice.com December 2005 PharmaVoice Volume 5 • Number 12 Download PDF
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Tracking the Trends: The Industry Across Sectors
From the clinic to the market to the boardroom, a plethora of factors are expected to change the healthcare landscape in the coming year and beyond. More than 135 distinguished industry executives, representing all of the major sectors of the life-sciences industry, provide their insights on the ...
By Taren Grom and Denise Myshko • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Table of Contents
About EDC: Michael Minor says EDC has a significant place in global data management strategies. Year In Preview From the clinic to the market to the boardroom, a plethora of factors are expected to change the healthcare landscape in the coming year and beyond. More than 135 distinguished industry...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's New
New Healthcare-related Products, Services, and Companies inChord and DWA Create New Agency The new agency’s focus is on providing pharmaceutical and healthcare marketing to clients in Italy and the surrounding region. inChord Communications Inc. and DWA have partnered to create a new agency, DWA ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
A Candid Visionary - Dr. Candace Kendle
November 2005 PharmaVOICE Photography: Donald Ventre/Ventre Photo Illustration With a mix of inspiration and perspiration, Candace Kendle, Pharm.D., has built a small pharma project management and monitoring service into a large, globally respected clinical research organization. A stalwart, neve...
By Kim Ribbink • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaOutlet
Dr. Ronald Salerno Contributed by Dr. Ronald Salerno Advancing the Science Last spring’s Drug Industry Association (DIA) workshop on pharmacogenomics reflected a much more mature, developed environment than previous workshops, paralleling the recent advances in the field. As an industry, we conti...
By Dr. Ronald Salerno • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Sales, Marketing, and R&D Trends from Industry Analysts Pharma Trax November 2005 Consumers Concerned about Unnecessary Medical Treatment A considerable number of U.S. adults are concerned about the frequency with which patients are medically overtreated by their doctors. This is a finding of...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
The Power of ePRO
In the past few years, drug developers and regulatory agencies have become increasingly receptive to the use of electronic patient-reported outcomes (ePRO) devices in clinical trials. The vast majority of patient-reported outcomes are still recorded in paper-based diaries, but a broad range of ap...
By Autumn Konopka • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Raise Your Voice -- Letters
November 2005 Lessons to be learned As illustrated by the recent issues surrounding the drug Vioxx, there are times when the desire for marketability of treatments may overlook small but potentially grave safety concerns arising from clinical trials. Of all the important lessons to be learned fro...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
Paperless Trials: Fact, Fiction, or a Little Bit of Both?
Electronic Data capture Paperless Trials: Fact, Fiction, or a Little Bit of Both? EDC has gone through many iterations in the past couple of years. While the technologies and processes have evolved significantly from the early days, the move to a completely paperless environment is still ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
What's New
i3 Creates Drug Safety Business The new business unit is responding to the industry’s need for greater vigilance regarding the safety of drugs. i3 has introduced i3 Drug Safety, a new business unit created to unite all of the organization’s epidemiology and drug-safety resources into one unit to ...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
PharmaTrax
PharmaTrax Cardiovascular Drug Market to Top $100 Billion by 2008 The worldwide market for prescription cardiovascular medications, which topped $75 billion in 2004, will surpass the $100 billion mark by 2008, according to a new report released by Kalorama Information titled The Worldwide M...
By PharmaVoice Team • Jan. 2, 2008 -
PharmaVoice Team/PharmaVoice
E-Media
New Electronic and Web-based Applications, Sites, and Technologies E-media PhRMA Website Educates Consumers on the Risks of Importing Drugs Citing a growing body of information that opening the U.S. borders to foreign drugs is risky and unsafe, the Pharmaceutical Research and Manufact...
By PharmaVoice Team • Jan. 2, 2008
Previous
